A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)

Cancer
Renal Cell Cancer (RCC)
Renal Cell Carcinoma

Results
Download

Study results

LPS WO29637 IMmotion151 Final Results February 2022 English (PDF, 1.0 MB)

LPS WO29637 IMmotion151 Final Results February 2022 German (PDF, 0.4 MB)

What is Clinical Research?

In clinical research, volunteers, researchers, and medical professionals work together toward a shared goal: better treatment outcomes for patients. Clinical trials are vital to their process. They are carefully designed and follow approved protocols.

A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)

Study results

LPS WO29637 IMmotion151 Final Results February 2022 English (PDF, 1.0 MB)

LPS WO29637 IMmotion151 Final Results February 2022 German (PDF, 0.4 MB)

What is Clinical Research?

For the latest version of this information please go to www.forpatients.roche.com

External Site

Directly contact Roche for questions

Contact the hospital directly

You are about to leave ForPatients

Thank you

Request a call back

Find participating medical centers and current study status in each of them

A Study of Atezolizumab in Combination With Bevacizumab Versus Sunitinib in Participants With Untreated Advanced Renal Cell Carcinoma (RCC)

For the latest version of this information please go to www.forpatients.roche.com